[Long-term management of anemia in chronic inflammatory bowel disease]

Z Gastroenterol. 2002 Apr;40(4):241-8. doi: 10.1055/s-2002-25154.
[Article in German]

Abstract

The development of a stepwise therapy, as detailed below, can be administered to the mostly young patients with Crohn's disease and ulcerative colitis on an out-patient basis and appropriate to their needs. This is true not only for the activity of the disease, but also for extraintestinal manifestations. The numerous variations in the stepwise anti-inflammatory therapy of chronic inflammatory bowel disease, but also in the substitution therapy of deficiency states and the therapy of accompanying extraintestinal diseases provide the gastroenterologist with the possibility of a long-term treatment tailored to the needs of the individual patient.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anemia, Iron-Deficiency / etiology
  • Anemia, Iron-Deficiency / therapy*
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / therapy*
  • Crohn Disease / complications
  • Crohn Disease / therapy*
  • Erythropoietin / administration & dosage*
  • Ferric Compounds / administration & dosage*
  • Ferrous Compounds / administration & dosage*
  • Humans
  • Recombinant Proteins

Substances

  • Ferric Compounds
  • Ferrous Compounds
  • Recombinant Proteins
  • Erythropoietin